Target intelligence / Profile preview

Peritoneal capillary–interstitium–peritoneal cavity interface

Molecular classification
Other (Physiological Interface)
01

Overview

The peritoneal capillary–interstitium–peritoneal cavity interface is a complex physiological barrier that regulates the exchange of water and solutes between the blood and the peritoneal space (Krediet, 1999). This interface consists of three distinct layers: the capillary endothelium, the interstitial tissue, and the mesothelial cell layer (Krediet, 1999). In the context of peritoneal dialysis, this system functions as a semi-permeable membrane where transport is governed by the Three-Pore Model, involving large pores, small pores, and ultra-small transcellular pores, specifically Aquaporin-1 (Rippe & Levin, 2000; Devuyst et al., 2002). The interface is the primary site of action for dialysis solutions containing osmotic agents like glucose or icodextrin, which create the necessary gradients for ultrafiltration and waste removal (Gokal & Mallick, 1999). Pathological changes such as mesothelial-to-mesenchymal transition, angiogenesis, and fibrosis—often driven by chronic exposure to high glucose concentrations or inflammation—can lead to membrane failure and encapsulating peritoneal sclerosis (Davies et al., 2001). Understanding the electrochemical and osmotic dynamics of this interface is critical for optimizing dialysis efficacy and preserving long-term membrane function in patients with end-stage renal disease.

Other names
Peritoneal membranePeritoneal barrierPeritoneal transport interface
02

Mechanism of action

Facilitation of diffusive and convective transport across a semi-permeable biological barrier via osmotic and electrochemical gradients.

03

Biological functions

Solute transportFluid homeostasisUltrafiltrationOsmotic regulation
04

Disease associations

End-stage renal diseaseChronic kidney diseasePeritonitisPeritoneal fibrosisEncapsulating peritoneal sclerosis
05

Safety considerations

Peritoneal membrane failureEncapsulating peritoneal sclerosisGlucose-induced mesothelial-to-mesenchymal transitionLoss of ultrafiltration capacity
06

Interacting drugs

Glucose

5 more in the full profile.

07

Biomarkers

D/P creatinine ratioUltrafiltration volumeCancer antigen 125 (CA-125)Interleukin-6 (IL-6)Vascular endothelial growth factor (VEGF)

Beyond the preview

Go deeper on Peritoneal capillary–interstitium–peritoneal cavity interface.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peritoneal capillary–interstitium–peritoneal cavity interface.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call